Document Type
Plan B - Open Access
Award Date
2019
Degree Name
Master of Science (MS)
Department
Biology and Microbiology
First Advisor
Greg Heiberger
Abstract
Irritable bowel syndrome with constipation (IBS-C) affects a large proportion of the population. It decreases quality of life for the patient both physically and mentally. Patients report higher levels of mental health issues and other gastrointestinal maladies compared to the normal population, in addition to an IBS diagnosis. Patients have increased healthcare visits and costs, raising insurance rates for all, and also results in more missed time from work. There are limited treatments available for IBS-C, and medicinal and non-medicinal modalities are differentially prescribed to patients throughout the country. Recently, serotonin has emerged as a key mediator of normal gut function, and thus, of IBS dysfunction. This chemical is implicated in physiological processes throughout the body, and serves as a key focus of IBS treatment. Current knowledge of IBS-C, treatments, and differences in care plans based on geography are explored in this review.
Format
application/pdf
Number of Pages
26
Publisher
South Dakota State University
Rights
Copyright © 2019 Meghan Schenk
Recommended Citation
Schenk, Meghan, "Irritable Bowel Syndrome with Constipation (IBS-C) Treatment Efficacy and the Emerging Importance of Serotonin" (2019). Biology and Microbiology Graduate Students Plan B Research Projects. 9.
https://openprairie.sdstate.edu/biomicro_plan-b/9